Skip to main content
. Author manuscript; available in PMC: 2016 Feb 15.
Published in final edited form as: Am J Cardiol. 2014 Nov 29;115(4):515–522. doi: 10.1016/j.amjcard.2014.11.037

Table 4.

Risk of cardiovascular events by electrocardiographic left ventricular hypertrophy (ECG-LVH) status

ECG-LVH
status
Participants/
events (n)
Person-
years
Event rate (95% CI)
per 10000 person-years
Model 1 Model 2 Model 3

HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
True Negative 4026/267 30809 8.67 (7.69, 9.77) Reference -- Reference Reference --
True positive 111/18 749 24.04 (15.14, 38.15) 2.79 (1.73, 4.49) <0.001 2.58 (1.54, 4.33) <0.001 1.77 (1.03, 3.04) 0.038
False positive 207/14 1569 8.92(5.29, 15.07) 1.03 (0.60, 1.77) 0.909 1.28 (0.74, 2.20) 0.379 1.20 (0.69, 2.09) 0.517
False negative 386/42 2756 15.24 (11.26, 20.62) 1.76 (1.27, 2.43) <0.001 1.83 (1.31, 2.56) <0.001 1.38 (0.98, 1.96) 0.069

Left ventricular hypertrophy by magnetic resonance imaging (MRI-LVH) was used as the gold standard

Model 1: Unadjusted

Model 2 adjusted for socio-demographic characteristics [age, sex, race and socioeconomic status]

Model 3 adjusted for model 1 plus clinical and anthropometric variables [body mass index, systolic blood pressure, blood pressure lowering drugs, diabetes, total cholesterol, lipid lowering drugs and smoking status]